Brief: Axcelead Drug Discovery Partners Enters Into Master Service Agreement For Drug Discovery Projects With Acadia Pharmaceuticals
19/09/2024 17:49
Sept 19 (Reuters) - AXCELEAD:
* AXCELEAD DRUG DISCOVERY PARTNERS ENTERS INTO MASTER
SERVICE
AGREEMENT FOR DRUG DISCOVERY PROJECTS WITH ACADIA
PHARMACEUTICALS
* AXCELEAD DRUG DISCOVERY PARTNERS: DETAILS OF FINANCIAL
TERMS
REGARDING MASTER SERVICE AGREEMENT AND NEW PROJECT ARE NOT
DISCLOSED
Source text for Eikon: ID:nBw1mm9Dma
Further company coverage: ACAD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acadia Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
U.S. STOCKS ON THE MOVE-Fortrea, Nuvation Bio, Acadia Pharmaceuticals
Acadia Pharma jumps after EU panel reverses opinion on neurological disorder drug
Brief: Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP